Showing 1931-1940 of 5909 results for "".
- Jeff Sieve Appointed CEO of Haag-Streit USAhttps://modernod.com/news/jeff-sieve-appointed-ceo-of-haag-streit-usa/2480518/Haag-Streit has announced that Jeff Sieve is the new Chief Executive Officer for Haag-Streit USA. Mr. Sieve begins his new role immediately, succeeding Ernest Cavin, PhD, who recently left the company to pursue new opportunities. Mr. Sieve will report to Haag-Streit Group management, le
- Heidelberg Engineering Showcases Technologies to Enhance the Future of Imaging Technology at ARVOhttps://modernod.com/news/heidelberg-engineering-showcases-technologies-to-enhance-the-future-of-imaging-technology-at-arvo/2482771/Heidelberg Engineering announced a portfolio of innovations aimed at redefining image quality, clinical research, and patient care in ophthalmology at ARVO. According to Heidelberg, Chameleon Imaging Research Platform is des
- Glaukos Expands its Preserflo MicroShunt Relationship With Santen Via New License Agreementhttps://modernod.com/news/glaukos-expands-its-preserflo-microshunt-relationship-with-santen-via-new-license-agreement/2479228/Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties. Financial ter
- Discovery of a New Drug for Diabetic Retinopathyhttps://modernod.com/news/discovery-of-a-new-drug-for-diabetic-retinopathy/2478858/A potentially effective treatment for diabetic retinopathy has been developed by an Université de Montréal (UdeM) scientist and investigator at Maisonneuve-Rosemont Hospital Research Centre (MRH-RC). Working with research scientist Pam Tsuruda of the
- Santen to Present Glaucoma/OcularHypertension Data at AAO 2020 Virtualhttps://modernod.com/news/santen-to-present-glaucoma-ocularhypertension-data-at-aao-2020-virtual/2478519/Santen announced that the following talks on glaucoma and ocular hypertension will be presented at the American Academy of Ophthalmology (AAO) Virtual 2020 meeting. Poster Topic: MicroShunt (or DE-128), an investigational surgical glaucoma implant designed to reduce intrao
- CoFi Announces Market-Wide Availability of its Multi-Provider Financing Solution with CareCredithttps://modernod.com/news/cofi-announces-market-wide-availability-of-its-multi-provider-financing-solution-with-carecredit/2482133/CoFi announced that patient payments with the CareCredit credit card can now be processed through CoFi’s multi-party payments platform. This market-wide availability follows a successful beta period involving joint CoFi and CareCredit customers. “We’ve
- FocalPoint Holdings Partners with GreenSky Patient Solutions to Enable 8,000 Ophthalmology Providers to Provide Patient Financinghttps://modernod.com/news/focalpoint-holdings-partners-with-greensky-patient-solutions-to-enable-8000-ophthalmology-providers-to-provide-patient-financing/2477162/FocalPoint Holdings announced a partnership with GreenSky Patient Solutions which enables FocalPoint Holdings’ network of 8,000 ophthalmology and optometry providers to offer flexible financing solutions, including revolving credit and installment loan products. “As the healthcare system i
- BostonSight Announces Leadership Changes to Advance Ocular Surface Care Worldwidehttps://modernod.com/news/bostonsight-announces-leadership-changes-to-advance-ocular-surface-care-worldwide/2485722/BostonSight announced a 5-year strategic roadmap designed to redefine ocular surface treatment through advancements in clinical research, professional education, and specialty lens technology. As part of the plan, BostonSight announced a new leadership structure ai
- HOYA Presents New Data on MiYOSMART iQ Spectacle Lenseshttps://modernod.com/news/hoya-presents-new-data-on-miyosmart-iq-spectacle-lenses/2485625/HOYA Vision Care recently announced interim 6-month data from its randomized controlled clinical trial evaluating the safety and efficacy of MiYOSMART iQ spectacle lenses to treat children 4 to 12 years of age who have progressive myopia. The company’s myopia control solution uses the defocu
- Alcon Launches PRECISION7 Weekly Contact Lenses in Canadahttps://modernod.com/news/alcon-launches-precision7-weekly-contact-lenses-in-canada/2485580/Key Takeaways PRECISION7 is the only 1-week replacement contact lens with the ACTIV-FLO System, deliverin